Hao Cai Selected Research

Anaphylaxis (Anaphylactic Shock)

12/2020	A case report on concurrent occurrence of systemic mastocytosis and myeloid sarcoma presenting with extensive skin involvements and the results of genetic study.
1/2020	Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hao Cai Research Topics

Disease

68	Neoplasms (Cancer) 01/2024 - 06/2005
22	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 01/2013
13	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2015
13	POEMS Syndrome (Syndrome, POEMS) 11/2021 - 06/2014
11	Inflammation (Inflammations) 02/2023 - 01/2013
10	Neoplasm Metastasis (Metastasis) 11/2023 - 03/2014
6	Stomach Neoplasms (Stomach Cancer) 11/2023 - 08/2009
6	Infections 07/2023 - 09/2012
5	Disease Progression 03/2024 - 01/2019
5	Carcinogenesis 01/2024 - 01/2014
5	Colorectal Neoplasms (Colorectal Cancer) 06/2023 - 12/2015
4	Fibrosis (Cirrhosis) 01/2024 - 01/2015
4	Multiple Myeloma 01/2022 - 06/2017
4	Insulin Resistance 01/2022 - 01/2018
4	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2017
4	Diarrhea 03/2019 - 05/2013
4	Pancreatitis 07/2014 - 10/2013
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 03/2024 - 06/2017
3	Rheumatoid Arthritis 01/2024 - 07/2017
3	Glioma (Gliomas) 01/2024 - 01/2021
3	Obesity 01/2023 - 08/2015
3	Paraproteinemias (Monoclonal Gammopathy) 01/2018 - 11/2016
3	Necrosis 01/2017 - 01/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024 - 01/2019
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 02/2024 - 01/2022
2	Triple Negative Breast Neoplasms 01/2024 - 03/2023
2	Hypoxia (Hypoxemia) 01/2024 - 10/2021
2	Staphylococcal Infections 11/2023 - 01/2022
2	COVID-19 08/2023 - 01/2023
2	Lymphoma (Lymphomas) 01/2023 - 06/2017
2	Reperfusion Injury 01/2022 - 01/2022
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2021
2	Infarction (Infarctions) 01/2022 - 01/2019
2	Ischemia 01/2022 - 01/2022
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 01/2022
2	Myocardial Infarction 01/2022 - 01/2019
2	Erdheim-Chester Disease 01/2022 - 10/2019

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2009
9	Biomarkers (Surrogate Marker)IBA 06/2023 - 10/2015
8	Messenger RNA (mRNA)IBA 06/2021 - 06/2009
7	EnzymesIBA 11/2023 - 05/2015
7	Therapeutic UsesIBA 04/2023 - 01/2017
7	Dexamethasone (Maxidex)FDA LinkGeneric 09/2022 - 10/2015
7	ProdrugsIBA 02/2022 - 03/2017
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2019 - 12/2014
6	Phosphotransferases (Kinase)IBA 01/2022 - 08/2015
6	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 10/2021
5	AntibodiesIBA 01/2023 - 01/2021
5	Lenalidomide (CC 5013)FDA Link 06/2021 - 10/2015
5	BaizhuIBA 03/2019 - 05/2013
5	oridoninIBA 01/2016 - 06/2012
4	CollagenIBA 01/2024 - 07/2014
4	Adenosine Triphosphate (ATP)IBA 01/2024 - 01/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 01/2013
4	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 09/2013
4	AntigensIBA 08/2023 - 01/2021
4	CytokinesIBA 01/2023 - 01/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2017
4	PolymersIBA 01/2022 - 11/2017
4	Estrogen ReceptorsIBA 01/2020 - 01/2016
4	Emodin (Archin)IBA 02/2019 - 10/2013
4	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 03/2015
3	Immunoglobulin M (IgM)IBA 03/2024 - 06/2017
3	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2024 - 12/2020
3	Antineoplastic Agents (Antineoplastics)IBA 01/2024 - 05/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 11/2020
3	Cell-Free Nucleic AcidsIBA 01/2023 - 08/2020
3	Contrast MediaIBA 01/2023 - 04/2017
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 08/2019
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2021 - 04/2017
3	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 04/2015
3	RNA (Ribonucleic Acid)IBA 01/2020 - 11/2017
3	cang er zi wanIBA 04/2019 - 02/2018
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 12/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024 - 06/2012
2	CarbonIBA 01/2024 - 09/2021
2	elemeneIBA 01/2024 - 01/2021
2	LipidsIBA 12/2023 - 08/2015
2	Glucose OxidaseIBA 11/2023 - 03/2023
2	Lactic Acid (Lactate)FDA LinkGeneric 11/2023 - 01/2022
2	NanovaccinesIBA 04/2023 - 03/2023
2	ParaffinIBA 01/2023 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2019
2	phytochlorinIBA 02/2022 - 01/2022
2	Photosensitizing Agents (Photosensitizers)IBA 02/2022 - 01/2022
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 01/2022
2	LigandsIBA 01/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 07/2015
2	Collagen Type I (Type I Collagen)IBA 07/2021 - 06/2014
2	GadoliniumIBA 02/2021 - 04/2017

Therapy/Procedure

44	Therapeutics 03/2024 - 06/2005
12	Drug Therapy (Chemotherapy) 11/2023 - 10/2015
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2018 - 01/2013
3	Hepatectomy 12/2022 - 01/2019
2	Photochemotherapy (Photodynamic Therapy) 01/2024 - 10/2021
2	Oral Administration 10/2023 - 01/2022
2	Aftercare (After-Treatment) 09/2022 - 04/2015
2	Liver Transplantation 06/2022 - 01/2022
2	Immunotherapy 01/2022 - 01/2021